Binah Capital Group, Inc.
BCGAbout the company
Binah Capital Group, Inc., together with its subsidiaries, operates in the wealth management industry. The company offers access to stocks, bonds, exchange-traded funds, and options execution services; and research, compliance, supervision, and accounting and related services for financial advisors.
Investment snapshot
Positive
4
BUY / PASS
Neutral / negative
3 / 9
NEUTRAL / FAIL
Median fair value
$2.12
+70.6% vs price
Models with upside
5 / 16
Positive margin of safety
Strongest signal
9 of 10 pass — Sleep objects
Key risk
No clean pass — all 8 investors flag at least one growth criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | BUY | FAIL | NEUTRAL | FAIL | PASS | FAIL | PASS | PASS | FAIL | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | ||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| Margin of Safety | -25.0% | +31.1% | N/A | N/A | N/A | +68.0% | +23.9% | +49.0% | N/A | +77.3% | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-31 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-31 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-31 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-31 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-31 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-11-12 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-11-12 Score computed: 2026-11-14 |
Where It Passes
- Cash Flow90% pass✓ 11✗ 1▾
9 of 10 pass — Sleep objects
Free Cash Flow Proxy$2.5M✓BuffettPositive and growingFCF Positive and Growing$7.8M✓LynchPositive and growingOperating Cash Flow$5.2M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.34%, ROA=3.29%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)4.0x✓Dreman< 8xP/E or FCF YieldP/E=31.0x, FCF Yield=24.1%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive2/3 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap37.6%✓Ackman>= 4%Price / FCF per Share4.1x✓Ackman<= 25Positive Operating Cash Flow frequency2/3 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$7.8M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+36.80%; #148/4519 (top 3.3%)✓OshaughnessyTop 10% of eligible cross-section - Valuation models83% pass✓ 5✗ 1▾
Models split on BCG at $1.24 — fair values range $0.99–$5.46
Graham fair value$0.99✗Graham-25.0% margin vs $1.24Buffett fair value$1.80✓Buffett+31.1% margin vs $1.24Munger fair value$3.87✓Munger+68.0% margin vs $1.24Pabrai fair value$1.63✓Pabrai+23.9% margin vs $1.24Akre fair value$2.43✓Akre+49.0% margin vs $1.24Ackman fair value$5.46✓Ackman+77.3% margin vs $1.24 - Efficiency67% pass✓ 2✗ 1▾
2 of 3 pass — Sleep objects
Revenue / Total Assets Change YoY2.53x -> 2.67x✓PiotroskiImproved YoYReinvestment Rate x ROIC12.6% (RR=100% x ROIC=12.6%)✓AkreReinvestment Rate * ROIC > 10%ROE (5-year)1/3 years above 12% (latest 12.6%)✗SleepROE > 12% in a majority of years
Where It Falls Short
- Growth0% pass✓ 1✗ 11▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 31.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency2/3 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth5.7%✓Ackman>= 5%Positive EPS Growth Frequency1/1 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Profitability19% pass✓ 11✗ 24▾
13 of 16 flag BCG's profitability — Graham, Buffett, Lynch +10 more
Return on Equity21.5%✓Munger> 15%✗AkreROE > 20% (3-year avg)Positive EPS (10 years)1/4 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)2/4 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-3.0%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$2.5M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 31.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE21.5%✓Lynch> 15%Net Income / Total Assets3.29%✓PiotroskiROA > 0ROA Change YoY-7.94% -> 3.29% (delta: +11.22%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.34%, ROA=3.29%✓PiotroskiCFO/Assets > ROAPre-Tax Income / Revenue3.5%✗Dreman>= 8%Net Income / Shareholders' Equity21.5%✓Dreman> 12%Margin of SafetyP/E=31.0x✗PabraiP/TBV < 1.5 or P/E < 15ROE (high and growing)FY2023: ROE=11.2%; FY2024: ROE=-32.7%; FY2025: ROE=12.6%✗AkreLatest 3 consecutive FYs: ROE > 15% in eachDiscount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency2/3 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity21.5%✓Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingROE (5-year)1/3 years above 12% (latest 12.6%)✗SleepROE > 12% in a majority of yearsNet income / market capitalization+23.88%; #227/6340 (top 3.6%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+21.53%; #728/5226 (top 13.9%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0482; #2536/5884 (top 43.1%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts31% pass✓ 4✗ 9▾
Split decision: 9 FAIL · 3 NEUTRAL · 3 PASS · 1 BUY
Overall verdict✗GrahamFAIL (1/7)✗BuffettFAIL (1/6)✗LynchFAIL (2/4)✓PiotroskiBUY (F-Score 6)✗DremanFAIL (2/9)•MungerNEUTRAL (2/3)✗PabraiFAIL (1/3)✓AkrePASS (2/5)✗MarksFAIL (2/4)✓AckmanPASS (4/8)✓TempletonPASS (4/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked) - Valuation33% pass✓ 12✗ 14▾
8 of 12 flag BCG's valuation — Graham, Lynch, Dreman +5 more
Price / Book Value per Share1.1x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Tangible-Book Ratio✗Graham<= 1.5xP/E x P/TBV✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 31.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)Price / EPS31.0x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)4.0x✓Dreman< 8xPrice / Tangible Book Value per ShareN/A (negative TBVPS)✗Dreman< 1.2x✗SchlossP/TBV <= 1.00x (app cutoff)Valuation ReasonablenessP/E=31.0x, OE Yield=12.3%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=31.0x, FCF Yield=24.1%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=31.0x, P/B=1.1x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per Share4.1x✓Ackman<= 25Price vs. Trailing Low115% of trailing low ($1.08)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+23.88%; #227/6340 (top 3.6%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+1.1091; #1313/6449 (top 20.4%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS31.0x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+9.2788; #332/5247 (top 6.3%)✓OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+36.80%; #148/4519 (top 3.3%)✓OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-22.01%; #4073/6202 (top 65.7%)✗OshaughnessyTop 10% of eligible cross-section - Debt & Leverage50% pass✓ 3✗ 2▾
2 of 4 pass — Asness and Schloss object
LT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYTotal Debt / Shareholders' Equity0.69✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xNegative debt-to-equity (higher means less debt)-0.6933; #2830/4210 (top 67.2%)✗AsnessTop 30% of eligible cross-sectionCurrent Assets / Current Liabilities✗SchlossCurrent ratio >= 1.50x (app cutoff)
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.
Shareholder Return
Fiscal 2025
Issued 0.7% of shares last year.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: revenue, net income, pre tax income, operating cash flow, depreciation amortization, capex. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
|
|---|---|---|---|---|---|---|---|---|
| Market Cap | $21.2Mcurrent | -- | -- | -- | $38.1Mest. | $34.2Mest. | -- | -- |
| Revenue | $196.3M↑8% | $50.6M↑9% | $46.5M↑12% | $48.7M | $187.1M↑11% | $168.9M↑1% | $168.0M | -- |
| Operating Income | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | $5.1M↑384% | $2.6M↑50% | $337.0K↑152% | $1.9M↑84% | $2.3M↑144% | -$5.3M↓1027% | $571.0K | -- |
| EPS (Diluted) | -- | $0.13↑63% | $0.00↑100% | $0.09↑50% | $0.04↑113% | $-0.32 | -- | -- |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| ROE | 21.5%↑273% | — | — | — | 12.6%↑139% | -32.7%↓392% | 11.2% | — |
| Total Debt | $16.3M | $16.3M | $16.7M | $17.2M | $17.7M↓10% | $19.6M↓6% | $20.8M | -- |
| Shareholders' Equity | $23.5M↑30% | $23.5M↑30% | $20.8M↑27% | $20.4M↑20% | $18.3M↑13% | $16.2M↑217% | $5.1M↑4% | $4.9M |
| Current Ratio | — | — | — | — | — | — | — | — |
| Debt / Equity | 0.69 | 0.69 | 0.81 | 0.84 | 0.97↓20% | 1.21↓70% | 4.08 | — |
| Operating Cash Flow | $7.8M↑103% | $3.1M↑228% | $1.1M↑1675% | $538.0K↓49% | $5.2M↑935% | -$617.0K↓124% | $2.6M | -- |
| Free Cash Flow | $7.8M↑109% | $3.1M↑246% | $1.1M↑1651% | $527.0K↓50% | $5.1M↑825% | -$702.0K↓128% | $2.5M | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Banking
BCG vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MITSUBISHI UFJ FINANCIAL GROUP INCMUFG | $245.7B | $21.83 | $74.2B | $10.8B | 8.8% | 1.12 | 19.9% | — | 2/7 | 1/6 | 1/4 | F-Score 5 | 3/9 |
| AMERICAN EXPRESS COAXP | $215.0B | $320.60 | $41.3B | $10.8B | 32.4% | 1.68 | — | — | 2/7 | 3/6 | 3/4 | F-Score 4 | 3/9 |
| Banco Santander, S.A.SAN | $175.9B | $12.21 | — | $16.6B | 12.5% | 0.02 | — | — | 2/7 | 1/6 | 2/4 | F-Score 4 | 5/9 |
| BARCLAYS BANK PLCATMP | $82.1B | $35.04 | $13.1B | $6.3B | 7.5% | 0.01 | — | — | 2/7 | 1/6 | 0/4 | F-Score 7 | 4/9 |
| BARCLAYS PLCBCS | $76.0B | $22.87 | $15.0B | $9.7B | 9.2% | 0.02 | — | — | 1/7 | 0/6 | 0/4 | F-Score 7 | 2/9 |
| FIRST CITIZENS BANCSHARES INC /DE/FCNCA | $25.7B | $2324.25 | $9.5B | $2.2B | 9.9% | 1.62 | — | — | 5/7 | 3/6 | 1/4 | F-Score 5 | 2/9 |
| KEYCORP /NEW/KEY | $22.7B | $21.46 | $7.5B | $1.8B | 9.0% | 0.49 | — | — | 2/7 | 1/6 | 1/4 | F-Score 6 | 4/9 |
| WEBSTER FINANCIAL CORPWBS | $12.6B | $77.57 | $2.9B | $1.0B | 10.6% | 0.08 | 50.7% | — | 2/7 | 1/6 | 1/4 | F-Score 7 | 2/9 |